Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain

Journal of Nuclear Medicine

Volumn 40, Issue 11, 1999, Pages 1832-1839

  Mariani, Giuliano ^a   Villa, Giuseppe ^b   Rossettin, Pier Franco ^b   Spallarossa, Paolo ^b   Bezante, Gian Paolo ^b   Brunelli, Claudio ^b   Pak, Koon Yan ^b   Khaw, Ban An ^b   Strauss, H William ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

99mTc labeling; Acute myocardial infarction; D glucaric acid; Perfusion imaging; Scintigraphic imaging

Indexed keywords

SACCHARIC ACID; TECHNETIUM 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; THORAX PAIN;

AGED; ANGINA, UNSTABLE; CHEST PAIN; FEMALE; GLUCARIC ACID; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0032739134     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Mair J, Smidt J, Lechleitner P, Dienstl F, Puschendorf B. A decision tree for the early diagnosis of acute myocardial infarction in nontraumatic chest pain patients at hospital admission. Chest. 1995;108:1502-1509.
2. Rich MW. Therapy for acute myocardial infarction. Clin Geriatr Med. 1996;12: 141-168.
3. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. N Engl J Med. 1984;311:1144-1147.
4. Pasternak RC, Braunwald E. Acute myocardial infarction. In: Isselbacher K, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw Hill; 1994:1066-1077.
5. McCarthy BD, Wong JB, Selker HP. Detecting acute cardiac ischemia in the emergency department: a review of the literature. J Gen Internal Med. 1990;5:365-373.
6. Selker HP, Zalenski HJ, Antman EM, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Working Group Report. Ann Emerg Med. 1997;29:13-87.
7. Green GB, Green SF. Markers of myocardial injury in the evaluation of the emergency department patient with chest pain. In: Wu AHB, ed. Cardiac Markers. Totowa, NJ: Humana Press; 1998:75-89.
8. Wackers FJ, Sokole EB, Samson G, et al. Value and limitations of thallium-201 scintigraphy in the acute phase of myocardial infarction. N Engl J Med. 1976;295:1-5.
9. Varetto T, Cantalupi D, Altieri A, Orlandi C. Emergency room technetium-99m sestamibi imaging to rule out ischemic events in patients with nondiagnostic electrocardiogram. J Am Coll Cardiol. 1993;22:1804-1808.
10. Bonte FJ, Parkey RW, Graham RT, Moore RT, Stokeley EM. A new method for radionuclide imaging of myocardial infarcts. Radiology. 1974;110:473-474.
11. Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation. 1986;74:501-508.
12. Khaw BA, Yasuda T, Gold HK, et al. Acute myocardial infarction imaging with indium-111-labeled monoclonal antimyosin Fab. J Nucl Med. 1987;28:1671-1678.
13. Croft CH, Rude RE, Lewis SE, et al. Comparison of left ventricular function and infarct size in patients with and without persistently positive technetium-99m pyrophosphate myocardial scintigrams after myocardial infarction: analysis of 357 patients. Am J Cardiol. 1984;53:421-428.
14. Marsh CA. Metabolism of D-glucuronolactone in mammalian systems: identification of D-glucaric acid as a normal constituent of urine. Biochem J. 1963;86: 77-86.
15. Marsh CA. Biosynthesis of D-glucaric acid in mammals: a free-radical mechanism? Carbohydr Res. 1986;153:119-131.
16. Orlandi C, Crane PD, Edwards S, et al. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med. 1991;32:263-268.
17. Yaoita H, Uehara T, Brownell AL, et al. Localization of technetium-99m-glucarate in zones of acute cerebral injury. J Nucl Med. 1991;32:272-278.
18. Ohtani H, Callahan RJ, Khaw BA, Fischman AJ, Wilkinson RA, Strauss HW. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. J Nucl Med. 1992;33:1988-1993.
19. Yaoita H, Fischman AJ, Wilkinson R, Khaw BA, Juweid M, Strauss HW. Distribution of deoxyglucose and technetium-99m glucarate in the acutely ischemic myocardium. J Nucl Med. 1993;34:1303-1308.
20. 99mTc-labeling method. Nucl Med Biol. 1992;19:669-677.
21. 99mTc-D-glucaric acid in humans. In: Bergmann H, Kroiss A, Sinzinger H, eds. Radioactive Isotopes in Clinical Medicine and Res. XXII. Basel, Switzerland: Birkhauser Verlag; 1997:359-364.
22. Roberts R. Enzymatic estimation of infarct size: thrombolysis induced its demise - will it now rekindle its renaissance? Circulation. 1990;81:707-710.
23. 99mTc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay. Circulation. 1984;69:1120-1128.
24. 99mTc-labeled glucarate. Circulation. 1997;95:1577-1584.
25. Beanlands RSB, Ruddy TD, Bielawski L, Johansen H, Palser A, Masika M. Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics. J Nucl Cardiol. 1997;4:274-282.
26. Khaw B-A, Nakazawa A, O'Donnell SM, Pak K-Y, Narula J. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol. 1997;4:283-290.
27. Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29:116-125.
28. McCarthy BD, Boshansky JR, D'Agostino RB, Selker HP. Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med. 1993;22:579-582.
29. Rozenman Y, Gotsman MS. The earliest diagnosis of acute myocardial infarction. Annu Rev Med. 1994;45:31-44.
30. Weaver WD, Eisenberg MS, Martin JS, et al. Myocardial Infarction Triage and Intervention Project: phase I - patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol. 1990;15:925-931.
31. Karlson BW, Herlitz J, Wiklund O, Richter A, Hjalmarson A. Early prediction of acute myocardial infarction from clinical history, examination, and electrocardiogram in the emergency room. Am J Cardiol. 1991;68:171-175.
32. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. J Am Coll Cardiol. 1991;17:1486-1491.
33. Stowers SA. Myocardial perfusion scintigraphy for assessment of acute ischemic syndromes: can we seize the moment? J Nucl Cardiol. 1995;2:274-277.
34. Gomez MA, Anderson JL, Karagounis LA, Muhlestein JB, Moers FB. An emergency department based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized trial (ROMOIO). J Am Coll Cardiol. 1996;28:25-33.
35. de Winter RJ, Koster RW, Schotveld JH, Sturk A, van Straalen JP, Sanders GT. Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction. Heart. 1996;75: 235-239.
36. DiSalvo TG, Paul SD, Lloyd-Jones D, et al. Care of acute myocardial infarction by noninvasive and invasive cardiologists: procedure use, cost and outcome. J Am Coll Cardiol. 1996;27:262-269.
37. Khaw BA, Strauss HW, Moore R, et al. Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. J Nucl Med. 1987;28:76-82.
38. 99mTc glucarate in necrotic myocardium [abstract]. J Nucl Med. 1996;37:175-176P.